Picosecond Laser for Ttreatment of Benign Pigmented Lesions

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether Pico laser is effective and safe in the treatment of benign pigmented lesions.

Clinical Trial Description

The Investigational device is a dual wavelength laser system developed for treatment of pigmented lesions and for tattoo removal. The base unit is a GentleMax system modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to 400mJ, and pulse duration of 700 ps. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Benign Pigmented Lesions

Clinical Trial Details

NCT number	NCT02146820
Study type	Interventional
Source	Syneron Medical
Contact
Status	Completed
Phase	N/A
Start date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05096247` - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device	N/A
Recruiting	`NCT02891239` - 785nm Picosecond Laser for Treatment of Benign Pigmented Lesions	N/A
Terminated	`NCT04861246` - Evaluation of Laser Treatment for Benign Pigmented Lesions by Non-invasive, Cellular Resolution Optical Coherence Tomography	N/A
Active, not recruiting	`NCT04208100` - Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands	N/A
Completed	`NCT03409952` - Lutronic LaseMD for Treatment of Benign Pigmented Lesions	N/A
Recruiting	`NCT02800525` - Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment	Phase 4
Completed	`NCT03774849` - PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles	N/A